Literature DB >> 1693546

Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast.

E P Sandgren1, N C Luetteke, R D Palmiter, R L Brinster, D C Lee.   

Abstract

Metallothionein-directed expression of TGF alpha in transgenic mice induced a spectrum of changes in the growth and differentiation of certain adult tissues. First, TGF alpha promoted a uniform epithelial hyperplasia of several organs without otherwise causing major alterations in tissue architecture. Second, in pancreas it promoted proliferation of both acinar cells and fibroblasts and focally altered acinar cell differentiation. The magnitude of this response was proportional to the level of local, tissue-specific TGF alpha expression and was reproduced when expression of TGF alpha was placed under the control of the elastase promoter, implying an autocrine or paracrine mechanism. Third, TGF alpha was oncogenic in vivo. It caused dramatic hyperplasia and dysplasia of the coagulation gland epithelium, which displayed evidence of carcinoma in situ, and in postlactational mammary gland it induced secretory mammary adenocarcinomas. Thus, TGF alpha displays characteristics of both a potent epithelial cell mitogen and an oncogenic protein in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693546     DOI: 10.1016/0092-8674(90)90075-p

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  196 in total

Review 1.  Role of mesenchymal-epithelial interactions in mammary gland development.

Authors:  G R Cunha; Y K Hom
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

2.  Adult pancreatic acinar cells give rise to ducts but not endocrine cells in response to growth factor signaling.

Authors:  Stacy A Blaine; Kevin C Ray; Reginald Anunobi; Maureen A Gannon; Mary K Washington; Anna L Means
Journal:  Development       Date:  2010-06-09       Impact factor: 6.868

Review 3.  Designing phenotyping studies for genetically engineered mice.

Authors:  C J Zeiss; J M Ward; H G Allore
Journal:  Vet Pathol       Date:  2011-09-19       Impact factor: 2.221

Review 4.  Transgenic models of pancreatic cancer.

Authors:  Andrew M Lowy
Journal:  Int J Gastrointest Cancer       Date:  2003

5.  Expression of transforming growth factor alpha in human tissues: immunohistochemical study and northern blot analysis.

Authors:  W Yasui; Z Q Ji; H Kuniyasu; A Ayhan; H Yokozaki; H Ito; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Effects of growth factors on proliferation on basal and luminal cells in human breast epithelial explants in serum-free culture.

Authors:  N P Perusinghe; P Monaghan; M J O'Hare; S Ashley; B A Gusterson
Journal:  In Vitro Cell Dev Biol       Date:  1992-02

Review 7.  Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Authors:  André L Mihaljevic; Christoph W Michalski; Helmut Friess; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2010-03-18       Impact factor: 3.445

8.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

9.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

10.  Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.

Authors:  F M Kong; M S Anscher; T Murase; B D Abbott; J D Iglehart; R L Jirtle
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.